Executive record

Erez Aminov

Director at MIRA PHARMACEUTICALS, INC.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:erez-aminovVersion: public-0As of: 2026-09-30

Not yet claimed15 published Claims7 sources
  • Executive
  • Director

Key Claims

Biography

Experienced biotechnology consultant and investor with over two decades in the biotech industry. Founded Locate Venture Corp., a strategy and investment consulting firm focused on early-stage biotech startups, and previously served as President of Finds4less Inc.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Current · dates not publishedChief Executive Officer and Chairman · Telomir Pharmaceuticals, Inc.
  2. 2026 to end not publishedExecutive title: Chief Executive Officer and Chairman · Organization not publishedMIRA DEF 14A director slate
  3. 2026 to end not publishedExecutive title: Chief Executive Officer · Organization not publishedTELO 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

7 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec def 14a · Source published: Jul 28, 2026 · Retrieved: Sep 13, 2026

    Supports 2 claims
    • Professional Role: Chief Executive Officer and Chairman at Telomir Pharmaceuticals, Inc. · Claim reviewed: Sep 13, 2026
    • Professional Role: Chief Executive Officer and Chairman at Telomir Pharmaceuticals, Inc. · Claim reviewed: Sep 13, 2026

  2. MIRA 10-K executive officers

    sec filing · Source published: Mar 31, 2026 · Retrieved: May 16, 2026

    Supports 3 claims
    • Executive company: Executive at MIRA Pharmaceuticals, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Executive Officer and Chairman · Claim reviewed: May 16, 2026
    • Other Company Role: Erez Aminov is also linked to Telomir Pharmaceuticals, Inc. as Chief Executive Officer. · Claim reviewed: May 16, 2026

  3. TELO 10-K executive officers

    sec filing · Source published: Mar 17, 2026 · Retrieved: May 16, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Telomir Pharmaceuticals, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Executive Officer · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  4. MIRA DEF 14A director slate

    sec filing · Source published: Jul 26, 2024 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Chair · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Executive · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at MIRA Pharmaceuticals, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Executive Officer and Chairman · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  5. Open source

    sec proxy · Source published: Jul 26, 2024 · Retrieved: Apr 29, 2026

    Supports 1 claim
    • Professional Role: Director at MIRA PHARMACEUTICALS, INC. · Claim reviewed: Sep 13, 2026

  6. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of MIRA PHARMACEUTICALS, INC. · Claim reviewed: Sep 13, 2026

  7. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Telomir Pharmaceuticals, Inc. · Claim reviewed: Sep 13, 2026